Nice pun.
Just looked it up, as I was curious. CanSino's one-dose vaccine is, according to Bloomberg, comparable to the Johnson & Johnson vaccine: it is less likely to protect people from getting mild symptoms than the two-dose vaccines offered by Pfizer and Moderna, but it is quite...